119 related articles for article (PubMed ID: 7673041)
1. Further analysis of radiobiological parameters from the First and Second British Institute of Radiology randomized studies of larynx/pharynx radiotherapy.
Chappell R; Nondahl DM; Rezvani M; Fowler JF
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):509-18. PubMed ID: 7673041
[TBL] [Abstract][Full Text] [Related]
2. Fifth progress report on the British Institute of Radiology fractionation trial of 3F-week or 5F-week treatment of larynx and pharynx.
Wiernik G; Bleehen NM; Brindle J; Meredith-Brown D; Churchill-Davidson IF; Davidson JC; Finney R; Fowler JF; Hadden RC; Halnan KE; Haybittle JL; Lansley IF; Howard N; O'Connell D; Phillips DL; Sambrock DK; Shanks W; Sicher K; Skeggs D; Stewart MA; Tudway RC
Br J Radiol; 1972 Oct; 45(538):754-6. PubMed ID: 4562371
[No Abstract] [Full Text] [Related]
3. First interim progress report on the second British Institute of Radiology Fractionation Study: short versus long overall treatment times for radiotherapy of carcinoma of the laryngopharynx.
Wiernik G; Alcock CJ; Bates TD; Berry RJ; Brindle JM; Dalby JE; Fowler JF; Gajek WR; Goodman S; Haybittle JL
Br J Radiol; 1989 May; 62(737):450-6. PubMed ID: 2653552
[TBL] [Abstract][Full Text] [Related]
4. Final report on the second British Institute of Radiology fractionation study: short versus long overall treatment times for radiotherapy of carcinoma of the laryngo-pharynx.
Wiernik G; Alcock CJ; Bates TD; Brindle JM; Fowler JF; Gajek WR; Goodman S; Haybittle JL; Henk JM; Hopewell JW
Br J Radiol; 1991 Mar; 64(759):232-41. PubMed ID: 2021797
[TBL] [Abstract][Full Text] [Related]
5. Fourth Progress Report on the British Institute of Radiology fractionation study on 3F-week or 5F-week treatment of larynx and pharynx.
Ellis F; Bleehen N; Brindle J; Brown DM; Churchill-Davidson IF; Davidson JC; Finney R; Fowler JF; Hadden R; Halnan KE; Haybittle JL; Howard N; Mahy D; Monypenny ER; O'Connell D; Phillips DL; Sambrook DK; Shanks W; Sicher K; Skeggs D; Stewart MA; Tudway RC; Wiernik G
Br J Radiol; 1971 Mar; 44(519):211-3. PubMed ID: 4926945
[No Abstract] [Full Text] [Related]
6. Dose, time, and fraction size issues for late effects in head and neck cancers.
Taylor JM; Mendenhall WM; Lavey RS
Int J Radiat Oncol Biol Phys; 1992; 22(1):3-11. PubMed ID: 1727126
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the normal-tissue reactions in patients treated with either 3F/Wk or 5F/Wk in the BIR (British Institute of Radiology) trial of radiotherapy for carcinoma of the laryngo-pharynx.
Rezvani M; Alcock CJ; Fowler JF; Haybittle JL; Hopewell JW; Wiernik G
Int J Radiat Biol; 1989 Nov; 56(5):717-20. PubMed ID: 2573668
[No Abstract] [Full Text] [Related]
8. Sensitivity of human squamous cell carcinoma of the larynx to fractionated radiotherapy.
Rezvani M; Fowler JF; Hopewell JW; Alcock CJ
Br J Radiol; 1993 Mar; 66(783):245-55. PubMed ID: 8472118
[TBL] [Abstract][Full Text] [Related]
9. Modelling the optimal radiotherapy regime for the control of T2 laryngeal carcinoma using parameters derived from several datasets.
Roberts SA; Hendry JH; Slevin NJ
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1173-82. PubMed ID: 9392560
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric intercomparison in the British Institute of Radiology fractionation study of 3F/week versus 5F/week in radiotherapy of laryngo-pharynx cancer.
Barrett JH; Davy TJ; Dixon-Brown A; Goodman D; Lawson RC; Ormsby PL; Saunders JE; Williams PC; Fowler JF; Wiernik G
Br J Radiol; 1990 Feb; 63(746):125-7. PubMed ID: 2178720
[TBL] [Abstract][Full Text] [Related]
11. Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix.
Leborgne F; Fowler JF; Leborgne JH; Zubizarreta E; Chappell R
Radiat Oncol Investig; 1997; 5(6):289-99. PubMed ID: 9436246
[TBL] [Abstract][Full Text] [Related]
12. Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients.
Suwinski R; Sowa A; Rutkowski T; Wydmanski J; Tarnawski R; Maciejewski B
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):399-412. PubMed ID: 12738315
[TBL] [Abstract][Full Text] [Related]
13. Time factors in larynx tumor radiotherapy: lag times and intertumor heterogeneity in clinical datasets from four centers.
Roberts SA; Hendry JH
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1247-57. PubMed ID: 10613320
[TBL] [Abstract][Full Text] [Related]
14. Final report of the general clinical results of the British Institute of Radiology fractionation study of 3F/wk versus 5F/wk in radiotherapy of carcinoma of the laryngo-pharynx.
Wiernik G; Bates TD; Bleehen NM; Brindle JM; Bullimore J; Fowler JF; Haybittle JL; Howard N; Laing AH; Lindup R
Br J Radiol; 1990 Mar; 63(747):169-80. PubMed ID: 2185865
[TBL] [Abstract][Full Text] [Related]
15. Seventh interim progress report of the british institute of radiology fractionation study of 3F/week versus 5F/week in radiotherapy of the laryngo-pharynx.
Wiernik G; Bates TD; Berry RJ; Brindle J; Bullimore J; Dalby JE; Flatman GE; Fowler JF; Hadden RC; Haybittle JL; Henk JM; Howard N; Ledda J; Lindup R; Phillips DL; Pointon RS; Sambrook DK; Skeggs D
Br J Radiol; 1982 Jul; 55(655):505-10. PubMed ID: 7150898
[TBL] [Abstract][Full Text] [Related]
16. Third progress report on the British Institute of Radiology fractionation study on 3F-week or 5F-week treatment of larynx and pharynx.
Ellis F; Brindle J; Churchill-Davidson IF; Davidson JC; Finney R; Fowler JF; Hadden R; Halnan KE; Haybittle JL; Howard N; Mahy D; Brown DM; Monypenny ER; O'Connell D; Phillips DL; Sambrook DK; Shanks W; Sicher K; Skeggs D; Stewart MA; Tudway RC; Wiernik G; Windeyer B
Br J Radiol; 1970 Aug; 43(512):558-60. PubMed ID: 4914825
[No Abstract] [Full Text] [Related]
17. The influence of radiotherapy treatment time on the control of laryngeal cancer: a direct analysis of data from two British Institute of Radiology trials to calculate the lag period and the time factor.
Roberts SA; Hendry JH; Brewster AE; Slevin NJ
Br J Radiol; 1994 Aug; 67(800):790-4. PubMed ID: 8087485
[TBL] [Abstract][Full Text] [Related]
18. Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: preliminary report of radiation therapy oncology group protocol 83-13.
Cox JD; Pajak TF; Marcial VA; Hanks GE; Mohiuddin M; Fu KK; Byhardt RW; Rubin P
Int J Radiat Oncol Biol Phys; 1990 Mar; 18(3):515-21. PubMed ID: 2180866
[TBL] [Abstract][Full Text] [Related]
19. A realistic closed-form radiobiological model of clinical tumor-control data incorporating intertumor heterogeneity.
Roberts SA; Hendry JH
Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):689-99. PubMed ID: 9635721
[TBL] [Abstract][Full Text] [Related]
20. Postoperative radiation of free jejunal autografts in patients with advanced cancer of the head and neck.
Cole CJ; Garden AS; Frankenthaler RA; Reece GP; Morrison WH; Ang KK; Peters LJ
Cancer; 1995 May; 75(9):2356-60. PubMed ID: 7712448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
